By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Celadon Pharmaceuticals Plc (CEL.L)

LSE Currency in GBP
£13.40
+£1.90
+16.52%
Last Update: 1 Jul 2025, 06:30
£9.23M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
£0.06 - £83.00
52 Week Range

CEL.L Stock Price Chart

Explore Celadon Pharmaceuticals Plc interactive price chart. Choose custom timeframes to analyze CEL.L price movements and trends.

There is nothing to show.

CEL.L Company Profile

Discover essential business fundamentals and corporate details for Celadon Pharmaceuticals Plc (CEL.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

31 Mar 2022

Employees

27.00

CEO

James Gareth Short

Description

Celadon Pharmaceuticals Plc, a pharmaceutical company, engages in the research, manufacture, and supply of cannabinoids for use in approved medicines. The company focuses on growing indoor hydroponic THC cannabis for use in medicinal products used to treat chronic pain. It also intends to conduct research into cannabinoids for use in chronic pain, as well as other conditions, such as autism and multiple sclerosis. The company was founded in 2018 and is headquartered in London, the United Kingdom.

CEL.L Financial Timeline

Browse a chronological timeline of Celadon Pharmaceuticals Plc corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 29 Sept 2025

Earnings released on 5 Jun 2025

Earnings released on 13 May 2025

Earnings released on 30 Sept 2024

Earnings released on 27 Sept 2024

EPS came in at -£0.02, while revenue for the quarter reached £31.50K.

Earnings released on 16 May 2024

EPS came in at -£0.02, while revenue for the quarter reached £31.50K.

Earnings released on 14 May 2024

EPS came in at -£0.02, while revenue for the quarter reached £33.50K.

Earnings released on 30 Sept 2023

EPS came in at -£0.02, while revenue for the quarter reached £33.50K.

Earnings released on 28 Sept 2023

EPS came in at -£0.07, while revenue for the quarter reached £8.00K.

Earnings released on 5 Jun 2023

EPS came in at -£0.03, while revenue for the quarter reached £4.00K.

Earnings released on 11 May 2023

EPS came in at -£0.06, while revenue for the quarter reached £12.74K.

Earnings released on 30 Sept 2022

EPS came in at -£0.03, while revenue for the quarter reached £6.50K.

Earnings released on 30 Jun 2022

EPS came in at -£0.25, while revenue for the quarter reached £11.26K.

Earnings released on 31 Mar 2022

EPS came in at -£0.13, while revenue for the quarter reached £5.50K.

Earnings released on 31 Dec 2021

EPS came in at -£0.03, while revenue for the quarter reached £1.00K.

Earnings released on 30 Sept 2021

EPS came in at -£0.01, while revenue for the quarter reached £1.00K.

Earnings released on 30 Jun 2021

EPS came in at -£0.02.

Earnings released on 31 Mar 2021

EPS came in at -£0.03.

Earnings released on 31 Dec 2020

EPS came in at -£12.21.

Earnings released on 30 Sept 2020

EPS came in at -£0.01.

CEL.L Stock Performance

Access detailed CEL.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
CEL.L
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
CEL.L
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More